NOT-OD-26-009 Effective October 1, 2025, all new NIH Notices of Award will include the following terms:
This award is subject to the termination provisions at 2 CFR 200.340. Pursuant to 2 CFR 200.340, by accepting an NIH award, the recipient agrees that continued funding for the award is contingent upon the availability of appropriated funds, recipient satisfactory performance, compliance with the Terms and Conditions of the award, and may also otherwise be terminated, to the extent authorized by law, if the agency determines that the award no longer effectuates the program goals or agency priorities, in line with 2 CFR 200.340(a)(4).
Any term or condition in this Notice of Award, including those incorporated by reference, that NIH is enjoined by court order from imposing or enforcing, shall not apply or be enforced as to any recipient or subrecipient to which that court order applies and while that court order is in effect.
Additionally, the new Notices of Award will reference 2 CFR 200 instead of 45 CFR Part 75, where applicable. These terms of award will be applied prospectively to new, renewal, supplement, or continuation awards issued on or after October 1, 2025. The updated language will also be incorporated into the FY26 version of the NIH Grants Policy Statement.
UCSF will continue with Award Acceptance with updated terms and conditions in the award record.